# Diagnostics Accelerator (partnership)

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/diagnostics-accelerator-partnership
- **Dataset:** https://optimly.ai/brand/diagnostics-accelerator-partnership.json
- **Markdown:** https://optimly.ai/brand/diagnostics-accelerator-partnership/llms.txt
- **Official website:** https://alzdiscovery.org
- **Slug:** diagnostics-accelerator-partnership
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** Building the world's largest harmonized longitudinal dataset of speech and biomarker data for Alzheimer's and pre-Alzheimer's patients, enabling scalable and accessible early detection.
Source: Brand's website (https://alzdiscovery.org) · 2026-10-04

- **Description:** An initiative by the Alzheimer’s Drug Discovery Foundation (ADDF) dedicated to developing scalable, accessible tools for the earliest detection of Alzheimer's disease, particularly through speech-based and digital biomarkers.
Source: Brand's website (https://alzdiscovery.org) · 2026-10-04

## Offerings

- **Core capabilities:** SpeechDx dataset; digital and speech-based diagnostic tools for Alzheimer's disease.
Source: Brand's website (https://alzdiscovery.org) · 2026-10-04

- **Pricing:** Licensing model for data access (e.g., SpeechDx dataset).
Source: Brand's website (https://alzdiscovery.org) · 2026-10-04

## Audience

- **Target industry:** Researchers, AI healthtech companies, pharmaceutical companies, healthcare providers, and patients at risk of Alzheimer's disease.
Source: Brand's website (https://alzdiscovery.org) · 2026-10-04

Page last updated 2026-10-17.